On the other hand, the interaction between VEGF-C/VEGF-D and VEGFR-3 triggers receptor phosphorylation and activates the Akt signaling pathway, which ultimately promotes the survival, proliferation, and migration of LECs, subsequently leading to the lymphangiogenesis in breast cancer (50). Here, FLT4 is linked to breast cancer.